Pharma shift
The pharmaceutical industry's focus on procedures and dealmaking could change significantly in this uncertain period, five Cambridge Executive MBA graduates say in a webinar for the What's Next? How to Survive and Thrive in a Post COVID-19 World series. Here's…
Investing in Cambridge drug discovery
PharmEnable raises £1.8 million for drug discovery expansion. PharmEnable, a venture supported by the Accelerate Cambridge programme at the Entrepreneurship Centre of Cambridge Judge Business School, said it has secured £1.8 million in a seed financing round led by Cambridge…
Biotech vs big pharma
Most approved "priority" medicines are developed by biotech rather than large pharmaceutical firms, says a two-decade study at the University of Cambridge Judge Business School. Biotech companies created 40 per cent more US Food & Drug Administration-approved "priority" drugs than…
Manhattan Project?
A "multiple-shots-on-goal" approach is needed to find coronavirus drugs, Cambridge Judge academics say in California Management Review. A many-shots-on-goal approach - not command and control - will most effectively develop vaccines and treatments for COVID-19 (coronavirus), Cambridge Judge Business School academics say in a new California Management Review article. Professor Christoph Loch While some have suggested…
Drug trials
An Executive MBA alumnus, Dr Rav Seeruthun, heads a Roche team that has developed a drug being tested to fight COVID-19. Dr Rav Seeruthun (EMBA 2013) of Cambridge Judge Business School, is heading a team at the Roche UK Medical Directorate that has developed…
AI and health
The Entrepreneurship Centre at Cambridge Judge supports new programme that uses artificial intelligence to tackle major NHS challenges. The Entrepreneurship Centre at Cambridge Judge Business School and the Eastern Academic Health Science Network (Eastern AHSN) are sponsoring a new programme…
Hispanic Outlook: Lost in translation Hispanics victimized by America’s third leading cause of death
David Lenihan, CEO of Ponce Health Sciences University and an alumnus of the Executive MBA programme at Cambridge Judge Business School (EMBA 2016), is interviewed by Hispanic Outlook, in which he discusses the make-up of medical school graduates from the…
Breaking Health: Can Tiber Health CEO David Lenihan disrupt how we teach our future physicians?
In the eyes of Tiber Health CEO David Lenihan, MD currently on Executive MBA class (EMBA 2016) at Cambridge Judge Business School, the “medical school model” is broken. Can his venture-backed startup Tiber Health teach future physicians more effectively and…
Expanding medical education
Executive MBA participant David Lenihan seeks to transform medical education to address a severe shortage of healthcare workers, using a once-struggling medical school in Puerto Rico as the launchpad. For David Lenihan, an Executive MBA participant at Cambridge Judge Business…
‘East and West’ – integrating Chinese and Western medical practices
Two Executive MBA participants from Cambridge Judge Business School presented a feasibility study to the Czech Ministry of Health on integrating Traditional Chinese Medicine. The University Hospital of Hradec Králové is affiliated with Charles University in the Czech Republic, where…
